Larimar Therapeutics (LRMR) News
NASDAQ: LRMRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.14-0.08 (-2.48%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LRMR news summary
We found 5 recent headlines mentioning Larimar Therapeutics (LRMR): 2 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, LRMR is down 2.48% at $3.14. The most recent story, "Larimar Therapeutics Completes BLA Submission for Nomlabofusp and Reports Third Quarter 2026 Financial Results", was published by Nasdaq on Nov 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Larimar Therapeutics headlines
- Larimar Therapeutics Completes BLA Submission for Nomlabofusp and Reports Third Quarter 2026 Financial ResultsLarimar Therapeutics, Inc. announced that it has completed its rolling Biologics License Application (BLA) submission to the FDA seeking accelerated approval of nomlabofusp for the treatment of…NasdaqLRMR, LEN.B
- Larimar Therapeutics Reports Third Quarter 2026 Financial and Business UpdateBALA CYNWYD, Pa., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare…GlobeNewswire
- Larimar Therapeutics, Inc. Completes Rolling BLA Submission for Nomlabofusp and Reports Preliminary Cash of $128.7 millionLarimar Therapeutics, Inc. announced completion of its rolling Biologics License Application submission to the U.S. Food and Drug Administration seeking accelerated approval of nomlabofusp for the…Nasdaq
- Larimar Therapeutics Announces Three Poster Presentations for the Nomlabofusp Program at the Upcoming International Congress for Ataxia ResearchBALA CYNWYD, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare…GlobeNewswire
- Tuesday Sector Leaders: Biotechnology, DrugsIn trading on Tuesday, biotechnology shares were relative leaders, up on the day by about 4.2%. Leading the group were shares of Myriad Genetics, up about 37.5% and shares of Larimar Therapeutics up…NasdaqMYGN, LRMR, ABOS, CPIX